AI assistant
Bioventus Inc. — Director's Dealing 2021
Feb 12, 2021
32934_dirs_2021-02-11_81bd6d0f-4b18-4064-8f18-15f9c4b093bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11
Reporting Person: Spindletop Healthcare Capital, L.P. (10% Owner)
Reporting Person: Spindletop Capital GP, L.P. (10% Owner)
Reporting Person: Spindletop GP Management, LLC (10% Owner)
Reporting Person: Melrose Evan S (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 3906395 | Indirect |
Footnotes
F1: The Class A Common Stock reported herein are held of record by Spindletop Healthcare Capital L.P. ("Spindletop"). Spindletop GP Management, LLC ("Spindletop GP") is the general partner of Spindletop Capital GP, L.P., which is the general partner of Spindletop. Mr. Melrose is the manager of Spindletop GP and may deemed to beneficially own the shares of Class A Common Stock held of record by Spindletop. Mr. Melrose disclaims ownership of such securities except to the extent of his pecuniary interest therein.